Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-01-22 | State Street Global Advisors, Inc.Société | -13,74M | 64,56k | Other Disposition | 13,77 - 16,87 | 49,32M | -21,79% |
| 2024-04-23 | State Street Global Advisors, Inc.Société | -131,23M | 351,73M | Other Disposition | 10,38 - 19,50 | 41,55M | -75,95% |
| 2025-11-18 | Mr. Christopher David WilksFinance Director, CFO & Executive Director | 233,76k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-18 | Mr. Christopher David WilksFinance Director, CFO & Executive Director | -122,57k | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-11-18 | Mr. Christopher David WilksFinance Director, CFO & Executive Director | 34,17k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-20 | Dr. James Pacey NewcombeMD, CEO & Executive Director | 50,48k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-20 | Dr. James Pacey NewcombeMD, CEO & Executive Director | 345,34k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-18 | Dr. Colin Stephen GoldschmidtInitié | -321,64k | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-10-16 | Ms. Nicola M. Wakefield EvansIndependent Non-Executive Director | 2,50k | 35,39k | Achat | 14,16 | 6,50k | 62,50% |
| 2025-10-03 | Dr. Katharine GilesIndependent Non-Executive Director | 1 000,00 | 14,35k | Achat | 14,35 | 4,60k | 27,78% |
| 2025-10-02 | Prof. Mark R. ComptonIndependent Non-Executive Chairman | 1,50k | 21,30k | Achat | 14,20 | 17,02k | 9,67% |
| 2025-10-01 | Prof. Christine Constance BennettIndependent Non-Executive Director | 1,10k | 15,62k | Achat | 14,20 | 8,20k | 15,49% |
| 2025-09-24 | Mr. Christopher David WilksFinance Director, CFO & Executive Director | -111,59k | 0,00 | Other Derivative Disposition | 21,62 | - | - |
| 2025-09-24 | Mr. Christopher David WilksFinance Director, CFO & Executive Director | -19,62k | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-09-24 | Dr. Colin Stephen GoldschmidtInitié | -265,92k | 0,00 | Other Derivative Disposition | 21,62 | - | - |
| 2025-09-24 | Dr. Colin Stephen GoldschmidtInitié | -46,75k | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-09-26 | Prof. Suzanne CroweNon-Executive Independent Director | 2,37k | 32,68k | Achat | 13,82 | 9,91k | 31,33% |
| 2025-09-26 | Ms. Kathryn Dianne SpargoNon-Executive Independent Director | 3,50k | 48,70k | Achat | 13,91 | 31,00k | 12,73% |
| 2025-09-02 | Mr. Christopher David WilksFinance Director, CFO & Executive Director | 3,75k | 0,00 | Derivative Exercise and Retained Stock | - | 630,56k | 0,60% |
| 2025-09-02 | Dr. Colin Stephen GoldschmidtInitié | 9,85k | 0,00 | Derivative Exercise and Retained Stock | - | 1,00M | 0,99% |
| 2022-09-27 | The Vanguard Group, Inc.Société | 7,60M | 180,82M | Achat | 15,65 - 23,86 | 28,86M | 35,72% |
| 2022-09-30 | The Vanguard Group, Inc.Société | -2,78M | 65,52M | Vente | 15,69 - 23,71 | 28,86M | -8,78% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
